BMC Nephrology

official impact factor 2.14

Open Access Email this article to a friend

Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis

Kavi J Littlewood*, Wolfgang Greiner, Dominique Baum and York Zoellner

BMC Nephrology 2007, 8:9 doi:10.1186/1471-2369-8-9

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.